FDA advisors say changes are need to reprocessing methods used by most hospitals for duodenoscopes, but that the devices involved in contamination incidents should stay on the market for life-saving endoscopic retrograde cholangiopancreatograpy (ERCP) procedures.
A majority of the FDA Gastroenterology-Urology Devices panel – about two-thirds – called for enhanced cleaning of the duodenoscopes, followed by sterilization, at a May 14-15 meeting. They said current...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?